prov:value
| - II. IT IS FURTHER ORDERED that respondents, directly or through any corporation, subsidiary, division, or other device, in connection with the manufacturing, labeling, advertising, promotion, offering for sale, sale, or distribution of Ecstacy or Herbal Ecstacy tablets or any other ephedrine product that is not a drug as defined by the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 321 as amende
|